Clinical Research in Southampton
Southampton Children's Hospital

A A A Text only | Accessibility | Privacy and cookies

Home
About the Trust
Our services
Patients and visitors
Our hospitals
Education
Research
Working here
Contact us

Browse site A to Z

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Search results

Go To Advanced Search

Search

You could also try: mixture (40), mix (143), blend (16), combination (297)

Carboplatin (AUC7)

Description: Chemotherapy Protocol GERM CELL CARBOPLATIN (AUC 7) Regimen • Germ Cell – Carboplatin (AUC7) Indication • Stage I seminoma of the testis with
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Germcell/Carboplatin-AUC7.pdf

Ibrutinib-Venetoclax

Description: Chemotherapy Protocol Chronic Lymphocytic Leukaemia IBRUTINIB-VENETOCLAX Regimen CLL – Ibrutinib & Venetoclax Indication • Ibrutinib plus V
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CLL/Ibrutinib-Venetoclax-Ver1.1.pdf

Pain relief in labour: epidurals and remifentanil explained - patient information

Description: Pain relief in labour: Epidurals and Remifentanil explained.
Url: /Media/UHS-website-2019/Patientinformation/Pregnancyandbirth/Pain-relief-in-labour-epidurals-and-remifentanil-690-PIL.pdf

Cytarabine1500

Description: Chemotherapy Protocol ACUTE MYELOID LEUKAEMIA CYTARABINE (1500mg/m2) In-Patient Regimen Regimen • Acute Myeloid Leukaemia –
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/AML/Cytarabine1500.pdf

Gemcitabine RT ver1

Description: Chemotherapy Protocol BLADDER CANCER GEMCITABINE RT Regimen Bladder – Gemcitabine RT Indication The treatment of muscle i
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Bladdercancer/Gemcitabine-RT-ver1.pdf

Vinorelbine (intravenous)

Description: Chemotherapy Protocol LUNG CANCER – NON-SMALL CELL (NSCLC) VINORELBINE (Intravenous) Regimen NSCLC - Vinorelbine (Intravenous) Indication Secon
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lung-cancer-non-small-cellNSCLC/Vinorelbineintravenousver12.pdf

Cyclophosphamide Topotecan v1.1

Description: Chemotherapy Protocol SARCOMA CYCLOPHOSPHAMIDE-TOPOTECAN Regimen Sarcoma – Cyclophosphamide-Topotecan Indicat
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Sarcoma/Cyclophosphamide-Topotecan-v1.1.pdf

1607TalimogeneRx108PFU (2)

Description: TALIMOGENE 108PFU/ml for MELANOMA INITIAL PRESCRIPTION – Second and Subsequent ADMINISTRATIONS O
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Skincancer/1607TalimogeneRx108PFU-2.pdf

Cisplatin (100)-Radiotherapy

Description: Chemotherapy Protocol HEAD AND NECK CANCER CISPLATIN (100) RT Regimen Head and Neck Cancer – Cisplatin (100) RT Indic
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Headandneckcancer/Cisplatin100-Radiotherapy.pdf

Cisplatin (100) RT (21 day)

Description: Chemotherapy Protocol HEAD AND NECK CANCER CISPLATIN (100) RT (21 day) Regimen Head and Neck Cancer – Cisplatin (100) R
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Headandneckcancer/Cisplatin-100-RT-21-day.pdf

391 to 400 of 466

Previous … 38 39 40 41 42 … Next